Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guiyuan Tablet for protracted opioid withdrawal symptoms
CTR20150266Phase 3Suspended
- Sponsor
- Yabao Pharmaceutical Group Co., Ltd.
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Guiyuan Tablet in opioid withdrawal, sponsored by Yabao Pharmaceutical Group Co., Ltd.. Started Aug 2015; status: suspended.
02
Drugs
Guiyuan Tablet
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on CTR20150266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150266.